Levamisole in Insulin-Dependent Diabetes Mellitus

W. E. Cobb, M. Molitch, S. Reichlin

Research output: Contribution to journalLetterpeer-review

13 Scopus citations

Abstract

To the Editor: If the hypothesis that human insulin-dependent diabetes mellitus (IDDM) may, in some instances, be an autoimmune disorder is correct, 1 it is reasonable to assume that suppression of the immune response should have a favorable effect on the course of the disorder in some patients. To test this hypothesis we recently studied the effect of levamisole (an agent used successfully in other autoimmune disorders, including rheumatoid arthritis2) on islet-cell function in three young adults with IDDM of three months' duration or less. Levamisole, at the doses used in this study, has been thought to be a stimulator.

Original languageEnglish (US)
Pages (from-to)1065-1066
Number of pages2
JournalNew England Journal of Medicine
Volume303
Issue number18
DOIs
StatePublished - Oct 30 1980

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Levamisole in Insulin-Dependent Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this